Default company panoramic image

Lung Therapeutics, Inc.

LTI leverages NIH validated and funded programs to develop first in class therapies for niche indications in lung injury and disease.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Austin, TX, USA
  • Currency USD

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.